AI Bias Analysis
4 models · Takes ~15 seconds
A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD patients.
Source
Stat News
Opens original article in a new tab
Leaving the WHO means the U.S. lacks access to necessary information about infectious disease.
52 health professionals returned home to 43 countries. Here are the unexpected challenges and opportunities they faced.
A top Republican is asking if the AMA's codes are helping to fuel health care fraud.
(MedPage Today) -- Updated findings from a European randomized trial continued to show that colonoscopy screening significantly reduced colorectal cancer (CRC) incidence, but its impact on CRC mortality was less clear. At 13 years of follow-up...
